Patents Assigned to Protia, LLC
  • ALCOHOLIC COMPOSITIONS HAVING A LOWERED RISK OF ACETALDEHYDEMIA
    Publication number: 20110046236
    Abstract: The present invention provides beverages and pharmaceutical compositions containing a deuterated alcohol according to Formula 1, and provides methods for their manufacture and use. The compositions of the invention are expected to ameliorate some of the negative side effects associated with the consumption of alcohol, such as hangover and facial flushing.
    Type: Application
    Filed: May 10, 2010
    Publication date: February 24, 2011
    Applicant: PROTIA, LLC
    Inventors: Anthony W. Czarnik, Jeffrey A. McKinney
  • DEUTERIUM-ENRICHED CAPECITABINE
    Publication number: 20110039872
    Abstract: The present application describes deuterium-enriched capecitabine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: October 27, 2010
    Publication date: February 17, 2011
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED BAZEDOXIFENE
    Publication number: 20110028454
    Abstract: The present application describes deuterium-enriched bazedoxifene, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: June 7, 2010
    Publication date: February 3, 2011
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • Deuterium-enriched nelarabine
    Patent number: 7846912
    Abstract: The present application describes deuterium-enriched nelarabine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Grant
    Filed: September 5, 2008
    Date of Patent: December 7, 2010
    Assignee: Protia, LLC
    Inventor: Anthony W. Czarnik
  • Deuterium-enriched capecitabine
    Patent number: 7842675
    Abstract: The present application describes deuterium-enriched capecitabine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Grant
    Filed: August 21, 2008
    Date of Patent: November 30, 2010
    Assignee: Protia, LLC
    Inventor: Anthony W. Czarnik
  • Deuterium-enriched risperidone
    Patent number: 7776866
    Abstract: The present application describes deuterium-enriched risperidone, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Grant
    Filed: September 11, 2008
    Date of Patent: August 17, 2010
    Assignee: Protia, LLC
    Inventor: Anthony W Czarnik
  • Deuterium-enriched atorvastatin
    Patent number: 7745480
    Abstract: The present application describes deuterium-enriched atorvastatin, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Grant
    Filed: April 4, 2008
    Date of Patent: June 29, 2010
    Assignee: Protia, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED ATOMOXETINE
    Publication number: 20100081720
    Abstract: The present application describes deuterium-enriched atomoxetine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: December 4, 2009
    Publication date: April 1, 2010
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED FOSAPREPITANT
    Publication number: 20100029592
    Abstract: The present application describes deuterium-enriched fosaprepitant, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: August 4, 2009
    Publication date: February 4, 2010
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED ARFORMOTEROL
    Publication number: 20090306215
    Abstract: The present application describes deuterium-enriched arformoterol, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: August 22, 2008
    Publication date: December 10, 2009
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED PALOSETRON
    Publication number: 20090227623
    Abstract: The present application describes deuterium-enriched palonosetron, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: September 11, 2008
    Publication date: September 10, 2009
    Applicant: Protia, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED LAPATINIB
    Publication number: 20090215802
    Abstract: The present application describes deuterium-enriched lapatinib, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: August 22, 2008
    Publication date: August 27, 2009
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED ASENAPINE
    Publication number: 20090209608
    Abstract: The present application describes deuterium-enriched asenapine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: August 21, 2008
    Publication date: August 20, 2009
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED OXYBUTYNIN
    Publication number: 20090156671
    Abstract: The present application describes deuterium-enriched oxybutynin, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: February 10, 2009
    Publication date: June 18, 2009
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • Deuterium-enriched oxybutynin
    Patent number: 7531685
    Abstract: The present application describes deuterium-enriched oxybutynin, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Grant
    Filed: June 1, 2007
    Date of Patent: May 12, 2009
    Assignee: Protia, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED ALENDRONATE
    Publication number: 20090118238
    Abstract: The present application describes deuterium-enriched alendronate sodium, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: August 21, 2008
    Publication date: May 7, 2009
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED GABEXATE MESYLATE
    Publication number: 20090105338
    Abstract: The present application describes deuterium-enriched gabexate mesylate, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: October 18, 2007
    Publication date: April 23, 2009
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED LAPAQUISTAT
    Publication number: 20090088416
    Abstract: The present application describes deuterium-enriched lapaquistat, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: September 19, 2008
    Publication date: April 2, 2009
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED PIOGLITAZONE
    Publication number: 20090082405
    Abstract: The present application describes deuterium-enriched pioglitazone, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: September 19, 2008
    Publication date: March 26, 2009
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED BUDESONIDE
    Publication number: 20090082319
    Abstract: The present application describes deuterium-enriched budesonide, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: August 21, 2008
    Publication date: March 26, 2009
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik